Simona Halep Banned for Four Years for Anti-doping Rule Violations

Twice Grand Slam champion Simona Halep has been banned for four years for two separate anti-doping rule violations, the International Tennis Integrity Agency (ITIA) said on Tuesday.

The 31-year-old former Wimbledon and French Open champion has been provisionally suspended since October 2022 after testing positive for banned blood-booster roxadustat at the U.S. Open last year.

“The first (charge) related to an Adverse Analytical Finding (AAF) for the prohibited substance roxadustat at the U.S. Open in 2022, carried out through regular urine testing during competition,” the ITIA said in a statement.

Halep has strongly denied knowingly taking the banned substance and said she had evidence to show that small amounts of the anaemia drug entered her system from a licensed supplement that was contaminated.

“The tribunal accepted Halep’s argument that they had taken a contaminated supplement, but determined the volume the player ingested could not have resulted in the concentration of roxadustat found in the positive sample. ”

“The second charge related to irregularities in Halep’s Athlete Biological Passport (ABP),” the ITIA added.

It said the ABP charge was also upheld as three independent experts were unanimous that “likely doping” was the explanation for the irregularities in Halep’s profile.

That is a drug approved for medical use in the European Union to treat the symptoms of anemia caused by chronic kidney failure. According to the EU’s medicines agency, it stimulates the body to produce more of the natural hormone erythropoietin, or EPO, which has long been a doping product favored by cyclists and distance runners.

Halep was accused of a second doping offense in May for for irregularities in her Athlete Biological Passport.

Halep is a 31-year-old from Romania who first reached No. 1 in the WTA rankings in 2017. She won the French Open in 2018 by beating Sloane Stephens in the final, and Wimbledon in 2019 by defeating Serena Williams in the title match.

(With inputs from Agencies)

Original news source